The Journal of Immunology, Vol 159, Issue 2 674-684, Copyright © 1997 by American Association of Immunologists

ARTICLES

Increased lymphocyte apoptosis in Fas ligand transgenic mice

J Cheng, C Liu, P Yang, T Zhou and JD Mountz
Department of Medicine, University of Alabama at Birmingham, and Veterans Administration Medical Center, AL 35294, USA.

Fas ligand (fasL) transgenic (Tg) mice were produced by introducing a murine fasL cDNA under the control of a TCR beta-chain enhancer minigene. Higher levels of fasL expression with increased biologic activity were observed in the Tg mice compared with non-Tg mice. Numbers of CD4+ CD8+ T cells in the thymus and T cells in the lymph node and spleen were lower in the fasL Tg mice compared with the non-Tg mice. This is consistent with a reduction in the size of the T cell areas in fasL Tg mice compared with non-Tg mice. Conversely, in fasL Tg mice, there was an increase in the number and size of apoptotic foci associated with phagocytic cells, as determined by in vivo TUNEL (TdT- mediated dUTP nick-end labeling) staining. Stimulation of non-Tg mice in vivo with anti-CD3 Ab for 3 days resulted in greatly increased apoptosis of CD4+ CD8+ thymocytes and lymph node T cells. Surviving thymocytes and T cells of lymph node and spleen expressed Fas at low levels. After similar stimulation of fasL Tg mice, however, a discreet population of surviving cells expressed high levels of Fas, indicating that a novel population of Fas apoptosis-resistant cells develops in these mice. These results indicate that high levels of fasL can result in both increased Fas-mediated apoptosis and the development of T cells that express high levels of Fas, but are resistant to Fas-mediated apoptosis.

This article has been cited by other articles:

				N. Abe, K. Kohu, H. Ohmori, K. Hayashi, T. Watanabe, K. Hozumi, T. Sato, S. Habu, and M. Satake Reduction of Runx1 Transcription Factor Activity Up-Regulates Fas and Bim Expression and Enhances the Apoptotic Sensitivity of Double Positive Thymocytes J. Immunol., October 1, 2005; 175(7): 4475 - 4482. [Abstract] [Full Text] [PDF]

				N. Zhang and Y.-W. He An essential role for c-FLIP in the efficient development of mature T lymphocytes J. Exp. Med., August 1, 2005; 202(3): 395 - 404. [Abstract] [Full Text] [PDF]

				O. Bohana-Kashtan and C. I. Civin Fas Ligand as a Tool for Immunosuppression and Generation of Immune Tolerance Stem Cells, November 1, 2004; 22(6): 908 - 924. [Abstract] [Full Text] [PDF]

				I. A. Camacho, M. Nagarkatti, and P. S. Nagarkatti Evidence for Induction of Apoptosis in T Cells from Murine Fetal Thymus following Perinatal Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Toxicol. Sci., March 1, 2004; 78(1): 96 - 106. [Abstract] [Full Text] [PDF]

				J. H. Liu, S. Wei, T. Lamy, P. K. Epling-Burnette, G. Starkebaum, J. Y. Djeu, and T. P. Loughran Jr Chronic neutropenia mediated by Fas ligand Blood, May 15, 2000; 95(10): 3219 - 3222. [Abstract] [Full Text] [PDF]

				T. Lamy, J. H. Liu, T. H. Landowski, W. S. Dalton, and T. P. Loughran Jr Dysregulation of CD95/CD95 Ligand-Apoptotic Pathway in CD3+ Large Granular Lymphocyte Leukemia Blood, December 15, 1998; 92(12): 4771 - 4777. [Abstract] [Full Text] [PDF]

				X. Su, J. Cheng, W. Liu, C. Liu, Z. Wang, P. Yang, T. Zhou, and J. D. Mountz Autocrine and Paracrine Apoptosis Are Mediated by Differential Regulation of Fas Ligand Activity in Two Distinct Jurkat T Cell Populations J. Immunol., June 1, 1998; 160(11): 5288 - 5293. [Abstract] [Full Text] [PDF]